Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Three months’ clinical outcomes from a nationwide non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis. Results from the DANBIO registry

Research output: Contribution to journalConference abstract in journalResearchpeer-review

View graph of relations
Original languageEnglish
Article numberOP07
JournalScandinavian Journal of Rheumatology
Volume45
Issue numberSuppl. 128
Pages (from-to)4-5
Number of pages2
ISSN0300-9742
Publication statusPublished - 2016

ID: 49894900